Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
Breast Cancer Blood Biorepository.
Open to Accrual
Defintions of terms and FAQ about clinical trials.
Julie Lang, M.D.
Other Trial Staff:
Kristy Watkins, R.N., Cristina De Leon, Coordinator, Kristy Sartor Massopust, Coordinator, America Casillas-Lopez, Coordinator, Yanli Wang, D.M., Akshara Singareeka Raghavendra, Coordinator, Sodech Kim, Coordinator
to see study documents.
You may participate in this study if:
Individuals of all racial and ethnic groups who are 18 years or older
Cohort 1: Women with a high-risk of breast cancer but no evidence of disease, including: (a) Women with BRCA1 or BRCA2 germline mutations; (b) Women with a family members with breast and/or ovarian cancer; (c) Women of Ashkenazi Jewish descent; (d) Women with a diagnosis of ovarian cancer; (e) Women with high mammographic breast density (BIRAD score 4-5); (f) Women with a history of atypical ductal hyperplasia Cohort 2: Women with stage I-III invasive ductal or lobular breast cancer, to be enrolled prior to definitive surgery for breast cancer Cohort 3: Women with stage IV invasive ductal or lobular breast cancer, to be enrolled at any time Cohort 4: Women with ductal or lobular carcinoma in situ, to be enrolled at the time of diagnosis and before definitive surgery Cohort 5: Normal controls, includes healthy family members of patients, patients with benign breast disorders, patients from families carrying a known genetic mutation who themselves are found not to carry the mutation.
Signed an approved study-specific informed consent and HIPAA
You may not participate in this study if:
Pregnancy (except for Cohort 5)
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.